Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4–NF-κB Pathway

Inflammation

Volumn 39, Issue 1, 2016, Pages 375-384

  Fan, Guanwei ^a   Jiang, Xiaorui ^a   Wu, Xiaoyan ^a   Fordjour, Patrick Asare ^a   Miao, Lin ^a   Zhang, Han ^a   Zhu, Yan ^a   Gao, Xiumei ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

inflammatory mediators; microRNA; tanshinone IIA; TLR4 NF B pathway

Indexed keywords

ACUTE PHASE PROTEIN; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MICRORNA; MICRORNA 105; MICRORNA 132; MICRORNA 145A; MICRORNA 147; MICRORNA 155; MICRORNA 184; MICRORNA 194; MICRORNA 29B; MICRORNA 34C; MICRORNA 383; MICRORNA 451A; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN; PROTEIN SICAM 1; PROTEOME; TANSHINONE IIA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ABIETANE DERIVATIVE; ANTIINFLAMMATORY AGENT; CYTOKINE; HERBACEOUS AGENT; MYD88 PROTEIN, MOUSE; TANSHINONE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE RAW 264.7; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HELA CELL LINE; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; DITERPENES, ABIETANE; DRUGS, CHINESE HERBAL; GENE EXPRESSION; HELA CELLS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICRORNAS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84958056877     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0259-1     Document Type: Article

References (32)

1. Zheng, S., Z. Ren, Y. Zhang, and Y. Qiao. 2014. Anti-inflammatory mechanism research of tanshinone IIA by module-based network analysis. Biomed Mater Eng. 24: 3815–3824.
2. You, Z., Y. Xin, Y. Liu, B. Han, L. Zhang, Y. Chen, Y. Chen, L. Gu, H. Gao, and Y. Xuan. 2012. Protective effect of Salvia miltiorrhizae injection on N (G)-nitro-D-arginine induced nitric oxide deficient and oxidative damage in rat kidney. Exp Toxicol Pathol. 64: 453–458.
3. Li, Y., Y. Guo, Y. Chen, Y. Wang, Y. You, Q. Yang, X. Weng, Q. Li, X. Zhu, B. Zhou, X. Liu, Z. Gong, and R. Zhang. 2015. Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis. Mol Med Rep 12: 1665–1676.
4. Tang, C., H. Xue, C. Bai, R. Fu, and A. Wu. 2010. The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine. 17: 1145–1149.
5. Chen, Y., X. Wu, S. Yu, X. Lin, J. Wu, L. Li, J. Zhao, and Y. Zhao. 2012. Neuroprotection of Tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats. PLoS ONE 7: e40165.
6. He, H., H. Tang, L. Gao, Y. Wu, Z. Feng, H. Lin, and T. Wu. 2015. Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis in rats. Mol Med Rep. 11: 4190–4196.
7. Xu, M., F.L. Cao, Y.F. Zhang, L. Shan, X.L. Jiang, X.J. An, W. Xu, X.Z. Liu, and X.Y. Wang. 2015. Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice. Acta Pharmacol Sin 36: 179–187.
8. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell. 140: 805–820.
9. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116: 281–297.
10. O'Connell, R.M., D.S. Rao, A.A. Chaudhuri, and D. Baltimore. 2010. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10: 111–122.
11. Huffaker, T.B., R. Hu, M.C. Runtsch, E. Bake, X. Chen, J. Zhao, J.L. Round, D. Baltimore, and R.M. O'Connell. 2012. Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep 2: 1697–1709.
12. Zhang, Y., R. Yan, and Y. Hu. 2015. Oxymatrine inhibits lipopolysaccharide-induced inflammation by down-regulating Toll-like receptor 4/nuclear factor-kappa B in macrophages. Can J Physiol Pharmacol 93: 253–260.
13. Colotta, F., P. Allavena, A. Sica, C. Garlanda, and A. Mantovani. 2009. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30: 1073–1081.
14. Tu, J., Y. Xing, Y. Guo, F. Tang, L. Guo, and T. Xi. 2012. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. Int Immunopharmacol. 14: 353–361.
15. Aviram, M. 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res. 33: S85–S97.
16. Fan, G.W., X.M. Gao, H. Wang, Y. Zhu, J. Zhang, L.M. Hu, Y.F. Su, L.Y. Kang, and B.L. Zhang. 2009. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol. 113: 275–280.
17. Xu, Y., D. Feng, Y. Wang, S. Lin, and L. Xu. 2008. Sodium Tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1pathways. J Clin Immunol. 28: 512–519.
18. Murray, P.J., and T.A. Wynn. 2001. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 11: 723–737.
19. Pascual, G., A.L. Fong, S. Ogawa, A. Gamliel, A.C. Li, V. Perissi, D.W. Rose, T.M. Willson, M.G. Rosenfeld, and C.K. Glass. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 437: 759–763.
20. Yuan, Z., M.A. Syed, D. Panchal, D. Rogers, M. Joo, and R.T. Sadikot. 2012. Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide. Int J Biochem Cell Biol. 44: 2032–2043.
21. Zhang, X., G. Wang, E.C. Gurley, and H. Zhou. 2014. Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS One. 9: e107072.
22. Asirvatham, A.J., C.J. Gregorie, Z. Hu, W.J. Magner, and T.B. Tomasi. 2008. MicroRNA targets in immune genes and the Dicer/argonaute and ARE machinery components. Mol. Immunol. 145: 1995–2006.
23. Martinez, R.T., F. Louafi, P.S. Friedmann, and T. Sanchez. 2009. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem. 284: 16334–16342.
24. Yang, L.L., J.Q. Liu, X.Z. Bai, L. Fan, F. Han, W.B. Jia, L.L. Su, J.H. Shi, C.W. Tang, and D.H. Hu. 2014. Acute downregulation of miR-155 at wound sites leads to a reduced fibrosis through attenuating inflammatory response. Biochem Biophys Res Commun 453: 153–159.
25. Zheng, Y., S. Xiong, P. Jiang, R. Liu, X. Liu, J. Qian, X. Zheng, and Y. Chu. 2012. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 52: 1307–1317.
26. Fu, Y., B. Liu, N. Zhang, Z. Liu, D. Liang, F. Li, Y. Cao, X. Feng, X. Zhang, and Z. Yang. 2013. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways. J Ethnopharmacol. 145: 193–199.
27. Murata, T., S. Kohno, C. Ito, M. Itoigawa, A. Sugiura, K. Hikita, and N. Kaneda. 2013. Inhibitory effect of carbazolequinone derivatives on lipopolysaccharide and interferon-γ-induced nitric oxide production in mouse macrophage RAW264.7 cells. J Pharm Pharmacol 65: 1204–1213.
28. Saccani, S., S. Pantano, and G. Natoli. 2011. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193: 1351–1360.
29. Botos, I., D.M. Segal, and D.R. Davies. 2011. The structural biology of Toll-like receptors. Structure 19: 447–459.
30. Taganov KD, Boldin MP, Chang KJ, Baltimore D.2006.Proc Natl Acad Sci USA.103:12481–12486
31. O'Connell, R.M., K.D. Taganov, M.P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 104: 1604–1609.
32. Bandyopadhyay, S., M.E. Long, and L.A. Allen. 2014. Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response. PLoS One 9: e109525.